- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02134652
Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Dengue fever has various levels of severity, from mild disease to severe hemorrhagic complications and shock. Dengue is endemic world-wide and has been found in the United States. The mortality from dengue fever can be as high as 15-20%, with nearly 22,000 deaths annually, most of them children (Reddy, 2013). There is no reliable way to immediately predict which children presenting with a fever during a Dengue fever outbreak will progress to more severe disease. Some children with dengue fever will improve with limited clinical interventions, but others require intensive therapy. Limited healthcare resources in developing countries make decisions on treatment or disposition difficult as many children and poor clinical decision increase morbidity and mortality. In more developed countries such as the United States, early identification of patients with dengue fever has the potential to identify children who may benefit from early interventions. Identifying those patients is the first step in exploring early therapies to effect mortality. Previous research has demonstrated that intrathoracic/ peritoneal fluid and gallbladder wall thickening is associated with worsening of the clinical prognosis for hospitalized patients with dengue fever (Michels, 2013). We will explore earlier presentations in the emergency department and outpatient department.
Our hypothesis is that the presence of gallbladder wall thickening and/or pleural effusions in children correlates with progression to Dengue hemorrhagic fever and Dengue shock. In addition, we hypothesize that sonographic imaging of pediatric patients presenting to the emergency department with a fever during a Dengue fever outbreak will change management and disposition. Our specific aim is to 1) compare the accuracy of bedside ultrasound detection of intra-thoracic fluid, peritoneal free fluid, and gallbladder wall thickening and physical exam versus physical exam alone in diagnosing dengue fever and 2) determine the association between sonographic features of dengue (intra-thoracic fluid and gallbladder wall thickening) and clinical outcome in children with dengue fever.
This study is a prospective observational clinical study in the emergency department, inpatient ward, intensive care unit, and outpatient department of the Angkor Hospital for Children in Siem Reap, Cambodia. Study subjects will include children 16 years or less, who present during the annual Dengue Fever outbreak with suspected Dengue fever. Subjects include children with an acute febrile illness, and two of the following: headache, retro-orbital pain, myalgias, arthralgia, rash, hemorrhagic manifestations, or plasma leakage (i.e. shortness of breath, abdominal distention/pain). Clinicians will determine their clinical suspicion of dengue, intended therapeutic interventions and disposition following a history and physical exam but before ultrasound imaging. Study personnel will perform diagnostic bedside ultrasound imaging of the gallbladder and peritoneal and pleural spaces (FAST exam) and the clinician again determine their clinical suspicion of Dengue, intended therapeutic interventions and disposition. Patients will be followed to determine clinical outcome, therapeutic interventions and disposition. The primary endpoint is progression of disease. The secondary endpoint will be change in clinical care provided in the emergency department related to ultrasound imaging.
Study Type
Contacts and Locations
Study Locations
-
-
-
Siem Reap, Cambodia
- Angkor Hospital for Children
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age >3 months and <16 years
- Clinical suspicion of dengue hemorrhagic fever. (Revised WHO Classification System)
- Not a prisoner or ward of the state
- Parents able and willing to give consent. Children older then 7 able and willing to give assent
Exclusion Criteria:
- Allergic to Ultrasound gel
- Prisoners or wards of the state
- Unstable patients
- Known pleural effusion, ascites, or gallbladder wall thickening.
Study Plan
How is the study designed?
Design Details
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Suspected Dengue
Children with an acute febrile illness, and two of the following: headache, retro-orbital pain, myalgias, arthralgia, rash, hemorrhagic manifestations, or plasma leakage (i.e.
shortness of breath, abdominal distention/pain) will all receive a diagnostic bedside ultrasound.
|
Patients enrolled in this study will undergo bedside ultrasound during their initial presentation to the emergency department. Ultrasound imaging protocols include the following:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Progression of Disease
Time Frame: Patients who are discharged from home will be contacted a maximum of 10 days after discharge to acquire follow up data. Those patients who are admitted to the hospital will monitored for the entirety of their hospital stay, an average of about 2 weeks.
|
Changes in clinical course or progression of disease in patients with Dengue Fever or Dengue Hemorrhagic Fever
|
Patients who are discharged from home will be contacted a maximum of 10 days after discharge to acquire follow up data. Those patients who are admitted to the hospital will monitored for the entirety of their hospital stay, an average of about 2 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Care
Time Frame: Patients will receive an ultrasound in the emergency department or outpatient department. Within 2 hours of study enrollment, the treating physician will be made aware of the test results and will be queried for changes in decision making.
|
Change in clinical care provided in the emergency department related to ultrasound imaging for patients presenting to the emergency department with symptoms of Dengue Fever.
|
Patients will receive an ultrasound in the emergency department or outpatient department. Within 2 hours of study enrollment, the treating physician will be made aware of the test results and will be queried for changes in decision making.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Disposition
Time Frame: Patients will receive an ultrasound in the emergency department or outpatient department. Within 2 hours of study enrollment, the treating physician will be made aware of the test results and will be queried for decision to admit versus discharge.
|
Change in disposition related to ultrasound imaging in patients presenting to the emergency department with symptoms of Dengue Fever
|
Patients will receive an ultrasound in the emergency department or outpatient department. Within 2 hours of study enrollment, the treating physician will be made aware of the test results and will be queried for decision to admit versus discharge.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Samuel D Licciardo, M.D., University of Massachusetts, Worcester
- Study Chair: Romolo Gaspari, M.D., Ph.D., University of Massachusetts, Worcester
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EUS-3325
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Disease Progression
-
Assiut UniversityNot yet recruiting
-
IRCCS San RaffaeleRecruitingGynecologic Cancer | Radiotherapy Side Effect | Survivorship | Radiotherapy; Complications | Progression, Disease | Progression, ClinicalItaly
-
Kaohsiung Medical University Chung-Ho Memorial...RecruitingProgression-Free SurvivalTaiwan
-
Grupo Hospital de MadridCompletedProgression Free SurvivalSpain
-
Assistance Publique Hopitaux De MarseilleCompleted
-
The Hong Kong Polytechnic UniversityAston University; Queensland University of Technology; Menicon Co., Ltd.Completed
-
The Hong Kong Polytechnic UniversityAston University; Queensland University of Technology; Menicon Co., Ltd.Completed
-
Illinois College of OptometryUnknown
-
Oupushifang Pharmaceutical Technology Co., Ltd.Seefunge Pharmaceutical Technology Co., Ltd.; AUTEK China Inc.Recruiting
-
Central Hospital, Nancy, FranceCompleted
Clinical Trials on diagnostic bedside ultrasound
-
Children's Hospital of PhiladelphiaCompletedTraumatic Lumbar PunctureUnited States
-
Timothy GleesonAngkor Hospital for ChildrenCompletedFever | DengueCambodia
-
Azienda Ospedaliero-Universitaria CareggiCompletedAbdominal Pain | Acute DiverticulitisItaly
-
Stony Brook UniversityUnknownHealthy VolunteersUnited States
-
University Hospital, AkershusCompletedAnesthesia Intubation Complication | Rapid Sequence Intubation | Non-fasting PatientsNorway
-
Eric SchwenkCompletedPostoperative Complications | Postoperative Nausea and Vomiting | Postoperative Nausea | Postoperative Vomiting | Postoperative Ileus | Aspiration VomitusUnited States
-
Odense University HospitalOdense Patient Data Explorative NetworkCompletedPyelonephritis | Hydronephrosis | UrosepsisDenmark
-
Kanuni Sultan Suleyman Training and Research HospitalUnknownPneumonia, Viral | COVIDTurkey
-
Samsung Medical CenterRecruitingDeep Vein ThrombosisKorea, Republic of
-
Fundación para la Investigación Biosanitaria del...CompletedShock | Lung Injury | Acute Respiratory Distress Syndrome | Pulmonary Edema | Extravascular Lung WaterSpain